Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report)’s stock price dropped 7.6% during mid-day trading on Friday . The company traded as low as $0.58 and last traded at $0.67. Approximately 500 shares changed hands during mid-day trading, a decline of 64% from the average daily volume of 1,390 shares. The stock had previously closed at $0.72.
Starpharma Price Performance
The company has a debt-to-equity ratio of 0.07, a current ratio of 4.94 and a quick ratio of 4.58. The stock has a 50-day simple moving average of $0.69 and a 200-day simple moving average of $0.65.
About Starpharma
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.
Featured Articles
- Five stocks we like better than Starpharma
- 3 Monster Growth Stocks to Buy Now
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Stock Average Calculator
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- How to trade using analyst ratings
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
